Amid a slower-than-expected ramp for its new 90-nm processor products, Transmeta revenue for the second quarter of fiscal 2004 was $ 6.0 million. The figure is up 15 percent from $ 5.2 million in the first quarter of 2004 and up 18 percent from $ 5.1 million in the second quarter of 2003. Despite the losses, the company claims it’s making progress with its new 90-nm processors, dubbed Efficeon. The chips are made on a foundry basis by Fujitsu. However, the products are taking longer-than-expected to ramp. Transmeta expect some additional Efficeon systems to ship in 2004; however, due to market dynamics and customer resource constraints, the majority of the Efficeon designs are expected to ship in 2005.

Amid a slower-than-expected ramp for its new 90-nm processor products, Transmeta revenue for the second quarter of fiscal 2004 was $ 6.0 million. The figure is up 15 percent from $ 5.2 million in the first quarter of 2004 and up 18 percent from $ 5.1 million in the second quarter of 2003. Despite the losses, the company claims it’s making progress with its new 90-nm processors, dubbed Efficeon. The chips are made on a foundry basis by Fujitsu. However, the products are taking longer-than-expected to ramp. Transmeta expect some additional Efficeon systems to ship in 2004; however, due to market dynamics and customer resource constraints, the majority of the Efficeon designs are expected to ship in 2005.